Science Explorer Back to mapMap
Discussion
Company · Coral Gables · United States

Catalyst Pharmaceuticals (United States)

catalystpharma.comROR OpenAlex
Research works
9
▲ 78% vs 2018-21
Citations
140
15.5 per fractional work
Top-10% rate
0.6%
all institutions 10.0%
Open access
35%
world 40%
International
20%
world 18%
Catalyst Pharmaceuticals (United States)

Not ranked overall: Catalyst Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Catalyst Pharmaceuticals (United States) work in?

In all years, 59% of research at Catalyst Pharmaceuticals (United States) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (59%), Neuroscience (17%), Biochemistry, Genetics and Molecular Biology (7%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 58.6% of its workMedicine: 5 fractional works · 58.6% of its workNeurology: 2 fractional works · 26.4% of its workPhysiology: 1 fractional works · 6.2% of its workSurgery: 0 fractional works · 3.4% of its workPsychiatry and Mental health: 0 fractional works · 3.1% of its workRheumatology: 0 fractional works · 3.1% of its workPharmacology: 0 fractional works · 3.0% of its workEpidemiology: 0 fractional works · 2.9% of its workOncology: 0 fractional works · 2.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.1% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.2% of its workHematology: 0 fractional works · 1.2% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.2% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workComplementary and alternative medicine: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workLife Sciences: 3 fractional works · 30.4% of its workNeuroscience: 2 fractional works · 17.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 15.5% of its workCognitive Neuroscience: 0 fractional works · 1.9% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 6.5% of its workMolecular Biology: 0 fractional works · 5.3% of its workBiochemistry: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 6.5% of its workPharmacology: 0 fractional works · 4.9% of its workToxicology: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 7.3% of its workSocial Sciences: 0 fractional works · 3.7% of its workDemography: 0 fractional works · 2.8% of its workSociology and Political Science: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 1.9% of its workApplied Psychology: 0 fractional works · 0.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.9% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.9% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workPhysical Sciences: 0 fractional works · 3.7% of its workMathematics: 0 fractional works · 2.8% of its workStatistics and Probability: 0 fractional works · 2.8% of its workChemistry: 0 fractional works · 0.9% of its workSpectroscopy: 0 fractional works · 0.9% of its workALL ITS WORKCatalystPharmaceuticals…9fractional works, all years
Life Sciences30%Physical Sciences4%Health Sciences59%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine558.6%
    1. Neuroscience217.3%
    2. Biochemistry, Genetics and Molecular Biology16.5%
    3. Pharmacology, Toxicology and Pharmaceutics16.5%
    1. Social Sciences03.7%
    2. Psychology01.9%
    3. Decision Sciences00.9%
    4. Economics, Econometrics and Finance00.9%
    1. Mathematics02.8%
    2. Chemistry00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Catalyst Pharmaceuticals (United States)?

The most cited paper from Catalyst Pharmaceuticals (United States) is "Habits and Goals in Human Behavior: Separate but Interacting Systems" (Wendy Wood, Asaf Mazar, David T. Neal, 2021), with 145 citations. Next come "Computational methods for case-cohort studies" (128) and "(1S, 3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction" (52).

Most cited papers
#PaperReleasedCitations
1 Habits and Goals in Human Behavior: Separate but Interacting Systems Wendy Wood, Asaf Mazar, David T. Neal · Perspectives on Psychological Science 20 Jul 2021 145
2 Computational methods for case-cohort studies Bryan M. Langholz, Jenny Jiao · Computational Statistics & Data Analysis 23 Dec 2006 128
3 (1S, 3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction Yue Pan, Madina R. Gerasimov, Trine Kvist et al. · Journal of Medicinal Chemistry Open access 30 Nov 2011 52
4 A Multisite, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin for Treating Cocaine Dependence Eugene C. Somoza, Douglas Winship, Charles W. Gorodetzky et al. · JAMA Psychiatry 10 Apr 2013 47
5 The Novel Phosphodiesterase Inhibitor NM-702 Improves Claudication-Limited Exercise Performance in Patients With Peripheral Arterial Disease Eric P. Brass, Richard M. Anthony, Frederick R. Cobb et al. · Journal of the American College of Cardiology Open access 29 Nov 2006 36
All 28 most cited papers, with filters and sorting

Which research topics does Catalyst Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Autoimmune Neurological Disorders and Treatments, Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders and Pain Mechanisms and Treatments.

Autoimmune Neurological …1Autoimmune Neurological Disorders and Treatments: 1 fractional worksMyasthenia Gravis and Thymoma: 0 fractional worksPeripheral Neuropathies and Disorders: 0 fractional worksPain Mechanisms and Treatments: 0 fractional worksSalivary Gland Tumors Diagnosis and Treatment: 0 fractional worksHereditary Neurological Disorders: 0 fractional worksAmyotrophic Lateral Sclerosis Research: 0 fractional worksNutrition and Health in Aging: 0 fractional worksEicosanoids and Hypertension Pharmacology: 0 fractional worksCancer, Stress, Anesthesia, and Immune Response: 0 fractional works
NeurologyPhysiologySurgeryCellular and Molecular Neuroscience2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Autoimmune Neurological Disorders and Treatments Neurology 1 works
  2. 2 Myasthenia Gravis and Thymoma Neurology 0 works
  3. 3 Peripheral Neuropathies and Disorders Neurology 0 works
  4. 4 Pain Mechanisms and Treatments Physiology 0 works
  5. 5 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
  6. 6 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
  7. 7 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  8. 8 Nutrition and Health in Aging Physiology 0 works
  9. 9 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
  10. 10 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.6%not open65.4%

World: 40% of research is openly available.

with international co-authors20.0%domestic only80.0%

World: 18% is written across borders.

How has Catalyst Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 78% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Catalyst Pharmaceuticals (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.000020%0.000040%Catalyst Pharmaceuticals (United States)0.0000034% in 202520102020

Fractional works of Catalyst Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Coral Gables

All research institutions in Coral Gables

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Catalyst Pharmaceuticals (United States). Posts are plain text and can be reported.